DERMATA THERAPEUTICS ($DRMA) posted quarterly earnings results for Q2 2026 on Tuesday, August 11th. The company reported earnings of -$0.74 per share, missing estimates of -$0.56 by $0.18. The company also reported revenue of $0, equaling estimates of $0 by $0.
Stock price change since market close: +43.66%
You can see Quiver Quantitative's $DRMA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DERMATA THERAPEUTICS Insider Trading Activity
DERMATA THERAPEUTICS insiders have traded $DRMA stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DRMA stock by insiders over the last 6 months:
- MUNERA MARIA E BEDOYA-TORO (SVP, Regulatory Affairs) purchased 1,000 shares for an estimated $1,270
- KATHLEEN D. SCOTT sold 11 shares for an estimated $13
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
DERMATA THERAPEUTICS Hedge Fund Activity
We have seen 7 institutional investors add shares of DERMATA THERAPEUTICS stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GEODE CAPITAL MANAGEMENT, LLC added 48,334 shares (+inf%) to their portfolio in Q1 2026, for an estimated $58,484
- UBS GROUP AG added 34,371 shares (+2778.6%) to their portfolio in Q1 2026, for an estimated $41,588
- STATE STREET CORP added 18,747 shares (+inf%) to their portfolio in Q2 2026, for an estimated $24,183
- CLEAR STREET GROUP INC. removed 17,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $20,570
- ADVISORY ALPHA, LLC added 10,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,900
- BANK OF AMERICA CORP /DE/ removed 3,457 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $4,182
- TOWER RESEARCH CAPITAL LLC (TRC) added 3,144 shares (+439.1%) to their portfolio in Q2 2026, for an estimated $4,055
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
